FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compositions for local application for the prevention and treatment of local eye pathologies, in particular inflammatory keratites and conjunctivitis and the dry eye syndrome, which contain as active ingredients polyunsaturated fatty acids of the omega-3 and omega-6 type, namely, EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (γ-linolenic acid), mixed with vitamin E acetate and combined into a stable composition in a hydrogel, that is in the disperse form in a water solution, containing one or more gel-forming polymers. The claimed compositions are especially recommended for application as artificial tears.
EFFECT: invention provides an increased efficiency of the prevention and treatment of eye pathologies.
15 cl, 15 tbl, 3 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ESTERS FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASES | 2012 |
|
RU2747953C2 |
| ESTERS FOR OPHTHALMOLOGICAL INFLAMMATORY DISEASES TREATMENT | 2012 |
|
RU2627438C2 |
| COMPOUND ETHERS FOR TREATMENT OF OPHTHALMOLOGICAL INFLAMMATORY DISEASES | 2012 |
|
RU2673230C1 |
| ESTERS FOR TREATING OPHTHALMIC INFLAMMATORY DISEASES | 2012 |
|
RU2707961C2 |
| ESTERS FOR TREATMENT OF OPHTHALMOLOGICAL INFLAMMATORY DISEASES | 2012 |
|
RU2640506C9 |
| COMPOSITION FOR EYE TREATMENT CONTAINING OMEGA-3 FATTY ACIDS AND OMEGA-6 FATTY ACIDS | 2005 |
|
RU2381025C2 |
| COMPOSITIONS BASED ON PARTIALLY FLUORINATED ALKANES, CONTAINING ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | 2019 |
|
RU2808451C2 |
| LIPIDS CONTAINING FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2004 |
|
RU2362566C2 |
| COMPOSITIONS OF THE COMPLEXES OF OMEGA-3 FATTY ACIDS | 2013 |
|
RU2633862C2 |
| COMPOSITION AND METHOD OF INCREASING STABILITY OF ADDITIVES TO FOOD PRODUCTS | 2012 |
|
RU2592572C2 |
